Recent developments in the use of viruses as vaccine vectors have been facilitated by a
better understanding of viral biology. Advances occur as we gain greater insight into the …

The cross-species transmission of lentiviruses from African primates to humans has selected
viral adaptations which have subsequently facilitated human-to-human transmission. HIV …

Vaccines based on historical virus isolates provide limited protection from continuously
evolving RNA viruses, such as influenza viruses or coronaviruses, which occasionally spill over …

Background The isolation of human monoclonal antibodies (mAbs) that neutralize a broad
spectrum of primary HIV-1 isolates and the characterization of the human neutralizing …

Early and persistent activation of complement is considered to play a key role in the
pathogenesis of COVID-19. Complement activation products orchestrate a proinflammatory …

West-central African chimpanzees (Pan troglodytes troglodytes) harbor strains of simian
immunodeficiency virus (SIVcpz) that are closely related to all three groups of human …

The antiretroviral restriction factor TRIM5 has recently emerged as an important mediator of
innate immunity and species-specific inhibition of retroviral replication in mammals. …

Self-amplifying messenger RNA (mRNA) of positive-strand RNA viruses are effective vectors
for in situ expression of vaccine antigens and have potential as a new vaccine technology …

Despite being the target of extensive research efforts due to the COVID-19 (coronavirus disease
2019) pandemic, relatively little is known about the dynamics of severe acute respiratory …

Viral emergence as a result of zoonotic transmission constitutes a continuous public health
threat. Emerging viruses such as SARS coronavirus, hantaviruses and henipaviruses have …